Will seek regulatory approval
Good news for parents worried about sending their kids to school amid the pandemic.
Pfizer announcing today its COVID-19 vaccine works for children ages 5 to 11.
The next step is getting approval from regulators in the U.S.. Britain and Europe to begin with.
Pfizer studied the vaccine in more than 2,000 kindergartners and elementary school-aged kids.
It gave them about a third of the typical dose and found they developed antibody levels just as strong as teens and young adults.

Man caught driving 3-wheeled pickup truck
2 from Niagara named to the Order of Canada
$3.5M of Crystal Meth seized from drug lab
NRP Searching for B&E Suspects
Welland CAO Optimistic for 2026
Niagara Clinics Help Coughs, Colds
Clifton Hill Construction in January
Gas Prices to Hold Steady: Analyst